NO20022468D0 - Genterapi av HIV-positive pasienter ved ekspresjon av membranforankrede GP41-peptider - Google Patents

Genterapi av HIV-positive pasienter ved ekspresjon av membranforankrede GP41-peptider

Info

Publication number
NO20022468D0
NO20022468D0 NO20022468A NO20022468A NO20022468D0 NO 20022468 D0 NO20022468 D0 NO 20022468D0 NO 20022468 A NO20022468 A NO 20022468A NO 20022468 A NO20022468 A NO 20022468A NO 20022468 D0 NO20022468 D0 NO 20022468D0
Authority
NO
Norway
Prior art keywords
membrane
hiv
anchored
peptides
expression
Prior art date
Application number
NO20022468A
Other languages
English (en)
Other versions
NO20022468L (no
Inventor
Meike-Dorothee Von Laer
Original Assignee
Pette Heinrich Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pette Heinrich Inst filed Critical Pette Heinrich Inst
Publication of NO20022468D0 publication Critical patent/NO20022468D0/no
Publication of NO20022468L publication Critical patent/NO20022468L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20022468A 1999-11-25 2002-05-24 Genterapi av HIV-positive pasienter ved ekspresjon av membranforankrede GP41-peptider NO20022468L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19957838A DE19957838C2 (de) 1999-11-25 1999-11-25 Gentherapie von HIV-Infizierten durch Expression von Membran-verankerten gp41-Peptiden
PCT/EP2000/011733 WO2001037881A2 (de) 1999-11-25 2000-11-24 Gentherapie von hiv-infizierten durch expression von membran-verankerten gp41-peptiden

Publications (2)

Publication Number Publication Date
NO20022468D0 true NO20022468D0 (no) 2002-05-24
NO20022468L NO20022468L (no) 2002-07-22

Family

ID=7931006

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022468A NO20022468L (no) 1999-11-25 2002-05-24 Genterapi av HIV-positive pasienter ved ekspresjon av membranforankrede GP41-peptider

Country Status (21)

Country Link
US (1) US7790870B1 (no)
EP (1) EP1234044B1 (no)
JP (1) JP2003529339A (no)
KR (1) KR100840430B1 (no)
CN (1) CN1425072A (no)
AT (1) ATE412757T1 (no)
AU (1) AU3004101A (no)
BR (1) BR0015942A (no)
CA (1) CA2392468A1 (no)
CZ (1) CZ20021764A3 (no)
DE (2) DE19957838C2 (no)
EA (1) EA006434B1 (no)
ES (1) ES2315247T3 (no)
HK (1) HK1049186B (no)
HU (1) HUP0203518A2 (no)
NO (1) NO20022468L (no)
PL (1) PL358785A1 (no)
SK (1) SK7132002A3 (no)
UA (1) UA78968C2 (no)
WO (1) WO2001037881A2 (no)
ZA (1) ZA200204710B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10257770A1 (de) * 2002-12-10 2004-07-08 Ruprecht-Karls-Universität Heidelberg Expression von Peptiden des zytoplasmatischen Bereiches von HIV-gp41 zur Hemmung viraler Infektionen
EP1660523A2 (de) * 2003-08-26 2006-05-31 BRD, vertreten durch das BM für Gesundheit und Soziale Sicherung, Letztvertreten durch den Präsidenten des Robert-Koch-Inst. Induktion antiviraler neutralisierender antikörper beim menschen und beim tier
WO2005056804A1 (ja) * 2003-12-11 2005-06-23 Takara Bio Inc. レセプターの機能の調節方法
GB0422439D0 (en) * 2004-10-08 2004-11-10 European Molecular Biology Lab Embl Inhibitors of infection
AU2006207181A1 (en) * 2005-01-24 2006-07-27 Yeda Research & Development Co. Ltd. HIV-1 gp41 fusion peptides for immunomodulation
WO2023030312A1 (zh) * 2021-08-30 2023-03-09 康霖生物科技（杭州）有限公司 一种用于艾滋病病毒感染基因治疗的基因序列构建体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935233A (en) * 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US5851828A (en) * 1991-03-07 1998-12-22 The General Hospital Corporation Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
DK0781343T3 (da) * 1994-09-08 2003-10-27 Vision 7 Gmbh Retrovirale vektorhybrider og anvendelsen deraf til gentransfer
CN1185811A (zh) * 1995-03-31 1998-06-24 H·沃尔夫 依赖于逆转录病毒样颗粒的抗原呈递系统
FR2762851B1 (fr) * 1997-04-30 1999-10-29 Inst Nat Sante Rech Med Construction et expression d'enveloppe chimerique de retrovirus par des vecteurs et compositions pharmaceutiques les contenant
AU3220500A (en) * 1999-02-02 2000-08-25 Uab Research Foundation, The Hiv drug resistance system

Also Published As

Publication number Publication date
EP1234044A2 (de) 2002-08-28
BR0015942A (pt) 2002-08-27
WO2001037881A9 (de) 2002-11-07
DE19957838C2 (de) 2002-11-21
EA200200598A1 (ru) 2002-12-26
HK1049186A1 (en) 2003-05-02
WO2001037881A2 (de) 2001-05-31
EA006434B1 (ru) 2005-12-29
ZA200204710B (en) 2003-05-15
SK7132002A3 (en) 2002-10-08
ATE412757T1 (de) 2008-11-15
PL358785A1 (en) 2004-08-23
CN1425072A (zh) 2003-06-18
DE50015431D1 (de) 2008-12-11
CZ20021764A3 (cs) 2003-02-12
EP1234044B1 (de) 2008-10-29
JP2003529339A (ja) 2003-10-07
US7790870B1 (en) 2010-09-07
KR100840430B1 (ko) 2008-06-20
WO2001037881A3 (de) 2001-12-13
NO20022468L (no) 2002-07-22
UA78968C2 (en) 2007-05-10
AU3004101A (en) 2001-06-04
KR20020060752A (ko) 2002-07-18
CA2392468A1 (en) 2001-05-31
HUP0203518A2 (en) 2003-02-28
HK1049186B (zh) 2009-02-27
ES2315247T3 (es) 2009-04-01
DE19957838A1 (de) 2001-06-13

Similar Documents

Publication Publication Date Title
ATE183515T1 (de) Zusammensetzungen die die hiv replikation inhibieren
DK1278534T3 (da) Fremgangsmåder og sammensætninger til svækkelse af multiplikationen af HIV-1
DK1171465T3 (da) Analoger til gastroinhibitorisk peptid og deres anvendelse til behandling af diabetes
WO2007149491A3 (en) Soluble stabilized trimeric hiv env proteins and uses thereof
DE60037450D1 (de) Funf-helix protein
DK1349944T3 (da) Latensassocieret peptid af TGF-beta til at bibringe farmaceutisk aktive proteiner latens
NO20022468L (no) Genterapi av HIV-positive pasienter ved ekspresjon av membranforankrede GP41-peptider
DE60044754D1 (de) Trans-lentivirales Vektor System
BR9710975A (pt) Genes de proteìna de adesão de superfìcie exposta de 120 kda imunodominante de ehrlichia chaffeensis
DE60236579D1 (de) Bakteriophagenvermittelte impfung
DK0811071T3 (da) Amplifikeringssekvenser hidrørende fra desmin-genet, vektorer indeholdende disse sekvenser og anvendelse heraf til fremstilling af proteiner
GB2368846B (en) Isolated Jaagsiekte retroviruses (JSRV), gene delivery vectors, and methods of use
FR2769916B1 (fr) Peptides issus du gene env du virus de l'immunodeficience feline et leurs applications immunoprotectrices et vaccinales
DK0781344T3 (da) Hidtil ukendt implantat og hidtil ukendt vektor til behandling af erhvervede sygdomme
WO2003029285A3 (en) Identification of cd8 epitopes from hiv-1 proteins for prevention and therapy of hiv infections
GB2336844A (en) Anti-hiv peptides and proteins
WO2003104262A3 (en) GP41 PEPTIDES AND METHODS USING SUCH PEPTIDES TO INHIBIT HIV FUSION WITH TARGET CELLS
DK1545594T3 (da) Bakteriofag-medieret immunisering mod Hepatitis
MXPA04004970A (es) Epitopos de linfocitos t en carboxipeptidasa g2.
SE9703287D0 (sv) Peptides
WO2000053789A3 (de) Retrovirale expressionsvektoren auf der basis von herv-ltr-sequenzen
TH31634A (th) เพพไทด์ชนิดใหม่ที่เหมาะสมสำหรับใช้ในการบำบัดรักษาที่กดภูมิคุ้มกันที่มีความจำเพาะต่อแอนติเจน
WO2002068464A3 (de) Fusionsprotein zum blocken des hiv nef-proteins
TH13136EX (th) แอนติเจนของ hiv

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application